Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

297 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Kidney injuries related to ipilimumab.
Izzedine H, Gueutin V, Gharbi C, Mateus C, Robert C, Routier E, Thomas M, Baumelou A, Rouvier P. Izzedine H, et al. Among authors: mateus c. Invest New Drugs. 2014 Aug;32(4):769-73. doi: 10.1007/s10637-014-0092-7. Epub 2014 Apr 1. Invest New Drugs. 2014. PMID: 24687600
Severe meningo-radiculo-neuritis associated with ipilimumab.
Bompaire F, Mateus C, Taillia H, De Greslan T, Lahutte M, Sallansonnet-Froment M, Ouologuem M, Renard JL, Gorochov G, Robert C, Ricard D. Bompaire F, et al. Among authors: mateus c. Invest New Drugs. 2012 Dec;30(6):2407-10. doi: 10.1007/s10637-011-9787-1. Epub 2012 Jan 11. Invest New Drugs. 2012. PMID: 22231551
[Immunotherapies and melanoma].
Routier É, Robert C, Mateus C. Routier É, et al. Among authors: mateus c. Bull Cancer. 2014 Dec;101 Suppl 2:S13-24. doi: 10.1684/bdc.2014.2054. Bull Cancer. 2014. PMID: 25776763 Review. French.
Renal effects of immune checkpoint inhibitors.
Izzedine H, Mateus C, Boutros C, Robert C, Rouvier P, Amoura Z, Mathian A. Izzedine H, et al. Among authors: mateus c. Nephrol Dial Transplant. 2017 Jun 1;32(6):936-942. doi: 10.1093/ndt/gfw382. Nephrol Dial Transplant. 2017. PMID: 28025384 Review.
Dose escalation phase 1 study of radiotherapy in combination with anti-cytotoxic-T-lymphocyte-associated antigen 4 monoclonal antibody ipilimumab in patients with metastatic melanoma.
Boutros C, Chaput-Gras N, Lanoy E, Larive A, Mateus C, Routier E, Sun R, Tao YG, Massard C, Bahleda R, Schwob D, Ibrahim N, Khoury Abboud RM, Caramella C, Lancia A, Cassard L, Roy S, Soria JC, Robert C, Deutsch E. Boutros C, et al. Among authors: mateus c. J Immunother Cancer. 2020 Aug;8(2):e000627. doi: 10.1136/jitc-2020-000627. J Immunother Cancer. 2020. PMID: 32819972 Free PMC article. Clinical Trial.
Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination.
Boutros C, Tarhini A, Routier E, Lambotte O, Ladurie FL, Carbonnel F, Izzeddine H, Marabelle A, Champiat S, Berdelou A, Lanoy E, Texier M, Libenciuc C, Eggermont AM, Soria JC, Mateus C, Robert C. Boutros C, et al. Among authors: mateus c. Nat Rev Clin Oncol. 2016 Aug;13(8):473-86. doi: 10.1038/nrclinonc.2016.58. Epub 2016 May 4. Nat Rev Clin Oncol. 2016. PMID: 27141885 Review.
297 results